1. Home
  2. EVCM vs NVAX Comparison

EVCM vs NVAX Comparison

Compare EVCM & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVCM
  • NVAX
  • Stock Information
  • Founded
  • EVCM 2006
  • NVAX 1987
  • Country
  • EVCM United States
  • NVAX United States
  • Employees
  • EVCM N/A
  • NVAX N/A
  • Industry
  • EVCM EDP Services
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EVCM Technology
  • NVAX Health Care
  • Exchange
  • EVCM Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • EVCM 2.0B
  • NVAX 2.0B
  • IPO Year
  • EVCM 2021
  • NVAX 1995
  • Fundamental
  • Price
  • EVCM $10.75
  • NVAX $9.76
  • Analyst Decision
  • EVCM Buy
  • NVAX Buy
  • Analyst Count
  • EVCM 11
  • NVAX 6
  • Target Price
  • EVCM $11.45
  • NVAX $17.83
  • AVG Volume (30 Days)
  • EVCM 68.3K
  • NVAX 7.2M
  • Earning Date
  • EVCM 11-12-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • EVCM N/A
  • NVAX N/A
  • EPS Growth
  • EVCM N/A
  • NVAX N/A
  • EPS
  • EVCM N/A
  • NVAX N/A
  • Revenue
  • EVCM $691,687,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • EVCM $4.47
  • NVAX N/A
  • Revenue Next Year
  • EVCM $5.08
  • NVAX N/A
  • P/E Ratio
  • EVCM N/A
  • NVAX N/A
  • Revenue Growth
  • EVCM 6.23
  • NVAX N/A
  • 52 Week Low
  • EVCM $6.22
  • NVAX $3.53
  • 52 Week High
  • EVCM $12.35
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • EVCM 60.86
  • NVAX 36.20
  • Support Level
  • EVCM $10.42
  • NVAX $9.52
  • Resistance Level
  • EVCM $10.90
  • NVAX $10.63
  • Average True Range (ATR)
  • EVCM 0.19
  • NVAX 0.57
  • MACD
  • EVCM 0.04
  • NVAX -0.12
  • Stochastic Oscillator
  • EVCM 88.61
  • NVAX 9.97

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: